Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Benitec Biopharma Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 15 | 18 | +3 |
| Shares | 359.4K | 1.52M | +1.16M (+322.9%) |
| Value | $1.84M | $6.46M | +$4.62M (+251.4%) |
New holders (8)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Suvretta Capital Management, LLC | 769,000 | $3.27M | 0.05% |
| Silverarc Capital Management, LLC | 467,256 | $1.99M | 1.05% |
| Renaissance Technologies LLC | 42,700 | $181.0K | 0.00% |
| BlackRock Inc. | 23,896 | $101.0K | 0.00% |
| State Street Corp | 21,000 | $89.0K | 0.00% |
| Private Wealth Advisors | 15,043 | $64.0K | 0.02% |
| Northern Trust Corp | 11,813 | $50.0K | 0.00% |
| Advisory Services Network, LLC | 3 | $0 | 0.00% |
Sold out (5)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| HighPoint Advisor Group LLC | 93,000 | $462.0K |
| Morgan Stanley | 84,725 | $438.0K |
| Virtu Financial LLC | 22,520 | $116.0K |
| Two Sigma Advisers, LP | 11,800 | $61.0K |
| Tower Research Capital LLC (TRC) | 129 | $1.00K |